Vivid E80/ Vivid E90/ Vivid E95

The Vivid E80/E90/E95 diagnostic ultrasound systems are primarily engineered for comprehensive cardiac imaging and analysis, while also serving a wide array of general ultrasound applications through diverse imaging modes and transducer options. These systems employ advanced digital ultrasound technology incorporating artificial intelligence for automated measurements, expanded quantitative analysis tools like multi-chamber strain imaging, enhanced 3D/4D visualization, and increased interoperability with DICOM data and third-party applications.

The Vivid E80, Vivid E90, and Vivid E95 are diagnostic ultrasound systems primarily intended for cardiac imaging and analysis, but also support a comprehensive range of general radiology applications. Designed for use by qualified physicians in various clinical settings including hospitals and private offices, these systems provide digital acquisition, processing, analysis, and display capabilities for imaging the human body and fluid. Supported clinical applications are extensive, covering fetal/obstetrics, abdominal, pediatric, small organs, cephalic, adult and pediatric cardiac, peripheral vascular, musculoskeletal, urology, transesophageal, transvaginal, transrectal, interventional guidance, and intraoperative vascular procedures. The systems operate in multiple modes, including 3D, real-time 3D (4D), B-mode, M-mode, PW Doppler, CW Doppler, Color Doppler, Color M Doppler, Power Doppler, Harmonic Imaging, Coded Pulse, and various combined modes. The Vivid E80/E90/E95 systems leverage established ultrasound technology with several enhancements. They feature a mobile console, advanced display options, and a variety of electronic array transducers. Significant new functionalities include Artificial Intelligence (AI) based features such as 'AI Auto Measure – 2D' for automated cardiac measurements on PLAX images, aiming to reduce user clicks and inter-observer variability, and 'AI Auto Measure – Spectrum Recognition' for automated Doppler spectra identification. Other additions include AFI 3.0 and Auto EF 3.0, which can now analyze both GE Healthcare raw data and DICOM images from third-party scanners; new Automated Function Imaging (AFI) modules for the right ventricle (AFI RV) and left atrium (AFI LA); the ML6-15-D and 6Vc-D transducers; 'HD Color' and 'Flexi-Light' for enhanced 3D/4D image perception; '4D Auto TVQ' for tricuspid valve quantification; DICOM PDF read capability; and a 'Launchpad' for integrating qualified third-party software applications.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How has the 'AI Auto Measure – 2D' feature been validated against expert manual measurements across diverse patient populations and image qualities to ensure its claimed reduction in inter-observer variability and time savings?; What is the clinical impact and diagnostic accuracy of the new AFI RV and AFI LA modules in assessing right ventricular and left atrial function compared to established reference standards, particularly in varying pathological conditions?; Regarding the 'Launchpad' feature for third-party apps, what specific qualification and ongoing compatibility verification processes are in place to ensure system stability, data security, and diagnostic integrity when integrating external software?; How do the 'HD Color' and 'Flexi-Light' visualization enhancements quantitatively improve diagnostic confidence, reduce interpretation time, or enhance the detection of subtle cardiac abnormalities in 3D/4D assessments compared to standard rendering techniques?; With Auto EF 3.0 and AFI 3.0 now supporting DICOM images from third-party scanners, what specific validation studies demonstrate consistent and reliable quantification across different vendor platforms, image acquisition protocols, and varying image qualities?